Royal Bank of Canada’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,936
Closed -$645K 6769
2020
Q1
$645K Buy
+5,936
New +$855K ﹤0.01% 3399
2019
Q4
Sell
-1,513
Closed -$218K 6979
2019
Q3
$218K Buy
+1,513
New +$221K ﹤0.01% 4400
2015
Q2
Sell
-52,380
Closed -$5.67M 6655
2015
Q1
$5.67M Hold
52,380
﹤0.01% 1523
2014
Q4
$4.86M Buy
+52,380
New +$4.63M ﹤0.01% 1684

Other funds holding LH

Royal Bank of Canada's LH Position: Q1 2026 in Review

Royal Bank of Canada increased its Labcorp (LH) stake by 19% in Q1 2026, buying an estimated $36.2M and bringing the position to 820,442 shares worth $219M. The position accounts for 0.04% of the portfolio, ranked #385.

Royal Bank of Canada first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $232M in Q3 2025. 1,034 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Royal Bank of Canada held 820,442 shares of Labcorp worth $219M as of Q1 2026.
  • Royal Bank of Canada bought 133,549 Labcorp shares in Q1 2026, an estimated $36.2M.
  • Labcorp made up 0.04% of Royal Bank of Canada's portfolio in Q1 2026, its #385 holding.
  • Royal Bank of Canada first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Labcorp position peaked at $232M in Q3 2025.
  • 1,034 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.